Growth Metrics

Novartis Ag (NVS) Net Cash Flow (2016 - 2025)

Novartis Ag's Net Cash Flow history spans 15 years, with the latest figure at -$2.1 billion for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 60.53% to -$2.1 billion in Q4 2025 year-over-year; TTM through Mar 2026 was -$3.8 billion, a 50.7% increase, with the full-year FY2025 number at -$600.0 million, up 63.33% from a year prior.
  • Net Cash Flow hit -$2.1 billion in Q4 2025 for Novartis Ag, down from -$860.0 million in the prior quarter.
  • Over the last five years, Net Cash Flow for NVS hit a ceiling of $9.9 billion in Q3 2021 and a floor of -$10.2 billion in Q2 2022.
  • Historically, Net Cash Flow has averaged -$757.0 million across 5 years, with a median of -$846.0 million in 2023.
  • Biggest five-year swings in Net Cash Flow: surged 420.63% in 2021 and later tumbled 18460.0% in 2022.
  • Tracing NVS's Net Cash Flow over 5 years: stood at $35.0 million in 2021, then tumbled by 18460.0% to -$6.4 billion in 2022, then soared by 192.22% to $5.9 billion in 2023, then plummeted by 189.94% to -$5.3 billion in 2024, then surged by 60.53% to -$2.1 billion in 2025.
  • Business Quant data shows Net Cash Flow for NVS at -$2.1 billion in Q4 2025, -$860.0 million in Q3 2025, and -$792.0 million in Q2 2025.